Overcoming barriers to cardiorenal optimisation: A practical guide for managing chronic hyperkalaemia
This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only.
A practical, case-based session exploring how healthcare professionals can overcome hyperkalaemia-related barriers to cardiorenal treatment optimisation. Highlighting the importance of maintaining appropriate RAAS inhibitor therapy and effective collaboration between primary and secondary care to support patients with heart failure and chronic kidney disease.
